Launch snapshot

FormBlends launched on What Launched Today on April 19, 2026. Ranked #8 of 15 launches on April 19, 2026. Tagged as Health & Fitness. Be the first to upvote this launch. Doctor-backed GLP-1 weight loss, HRT, and peptide therapy.

About FormBlends

FormBlends is a telehealth platform for GLP-1 weight loss, hormone replacement therapy, and peptide programs. Our GLP-1 plans use semaglutide and tirzepatide, the same compounds behind Ozempic and Mounjaro, with clinical trials showing up to 22.5% body weight reduction. We also offer HRT and a full range of peptide therapies for performance, recovery, and overall wellness. Every program starts with a licensed physician who builds a personalized plan for you. No insurance hoops, no waiting rooms, no overpriced clinic visits. Pharmaceutical-grade compounds shipped straight to your door at a fraction of what brand names cost. We handle prescriptions, provider check-ins, and ongoing support so you can just focus on results. Free consultation to start, most people have their plan within days.

Leave a review

Related launches

Trending today

Other startups launched in the last 24 hours.

Alternatives

Explore alternative products in the same space.